Asia-Pacific Journal of Clinical Oncology

Papers
(The median citation count of Asia-Pacific Journal of Clinical Oncology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
40
Author List24
Unmet Need for Breast Cancer Screening Among South Asian Women in Victoria22
Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma18
Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma15
Issue Information15
Retrospective review of safety and efficacy of anlotinib in advanced osteosarcoma with metastases after failure of standard multimodal therapy14
The Best of the Best Oral Abstracts13
Issue Information13
Highlighted Lectures and Awards 202212
Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center12
Poster Abstracts11
TNT: Raising more questions than answers?10
Taxane‐based versus platinum‐based chemotherapy in early recurrent gastric cancer after radical surgery with S‐1 adjuvant chemotherapy: A multi‐institutional retrospective analysis10
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma10
Treatment outcomes of patients with involved resection margin after rectal cancer surgery: A nationwide population‐based cohort study in South Korea9
Issue Information9
Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unit9
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry9
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD‐1 or PD‐L1 inhibitor9
Comparison of direct medical care costs between patients receiving care in a designated palliative care unit and the usual care units8
Differences in ultrasonographic features between males and females with breast cancer of the luminal A and luminal B molecular subtypes8
8
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)8
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer8
8
COSA President's Welcome7
AUTHOR INDEX7
Poster Abstracts7
2021 Hunter Cancer Research Symposium7
2021 COSA ASM Exhibitor Profiles7
NATIONAL SPEAKERS7
6
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific6
Issue Information6
Invited speakers6
Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 20196
Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia6
International Presenters6
Suitability of endobronchial ultrasound‐guided transbronchial needle aspiration samples for programmed death ligand‐1 testing in non‐small cell lung cancer, the Bristol experience6
Rapid Fire presentation abstracts6
6
Issue Information6
Poster Abstracts6
Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center5
ANZUP Chair Welcome5
Oral Abstracts5
Issue Information5
A prospective study of diagnostic accuracy of multidisciplinary team and radiology reporting of preoperative colorectal cancer local staging5
Issue Information5
An Australian mainstream genetic testing program: Clinicians views about current and future practices5
National Speakers5
5
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research5
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival5
Acknowledgements5
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series5
AUTHOR INDEX5
2023 COSA ASM Exhibitor Profiles5
Hong Kong Urological Association–Hong Kong Society of Uro‐Oncology consensus statements on the management of advanced prostate cancer—2019 Updates5
Clinical results of total en bloc spondylectomy using a single posterior approach in spinal metastasis patients: Experiences from Thailand5
Young Oncologist Oral Presentation Abstracts5
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia5
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells4
Nomogram based on the systemic immune‐inflammation index for predicting the prognosis of diffuse large B‐cell lymphoma4
A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective4
The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases4
Author Index4
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review4
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience4
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database4
Neoadjuvant Chemotherapy With Chemoradiotherapy for Patients With Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma— Retrospective Review From a Tertiary Care Hospital4
Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors4
Real‐world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study4
Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies4
Prevalence and risk factors of chemotherapy‐induced oral mucositis among adult cancer patients at the cancer unit of Mbarara Regional Referral Hospital4
Utilization of clinical practice guidelines for cancer care in routine practice and during the coronavirus disease 2019 pandemic in India4
Molecular Mechanisms of circKIF4A in Breast Cancer Progression4
Molecular basis and targeted therapies for radioiodine refractory thyroid cancer3
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?3
Corrigendum3
Prevention of docetaxel‐associated febrile neutropenia with primary granulocyte colony‐stimulating factor in Chinese metastatic hormone‐sensitive and castration‐resistant prostate cancer patients3
Issue Information3
Life‐threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia‐Singapore 2003 and 2010 clinical trials: A risk prediction model3
The Case for Shared Decision‐making in Oncology and Why the Philippine Healthcare System is Primed for It3
Exercise recommendations and referral patterns of oncology professionals3
The role of surveillance imaging for resected high‐risk melanoma3
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia3
Adjuvant Radiotherapy After Surgical Resection Improves Local Control in Adrenocortical Carcinoma3
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features3
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma3
The impact of multidisciplinary cancer meetings in guiding treatment intent in patients with upper tract urothelial carcinoma3
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA15223
The molecular characteristics of non‐small cell lung cancer in the Northern Territory's Top End3
Olaparib dose re‐escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series3
COSA President's Welcome3
Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohort3
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette–Guerin3
Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer3
A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof‐of‐concept trial3
TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment3
Real‐world data on efficacy and safety of osimertinib in non‐small cell lung cancer patients with EGFR T790M mutation detected by first and repeat rebiopsy3
“Artificial Intelligence in NAFLD Diagnosis: A New Frontier in Managing Metastatic Prostate Cancer Risk”3
The therapeutic effects of berberine for gastrointestinal cancers3
Survival analysis for older patients with epidermal growth factor receptor mutation‐positive advanced non‐small cell lung cancer after progression of first‐line gefitinib3
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis3
3
Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer3
COSA COMMITTEES3
3
Incidence and risk factors for neoplasia in inflammatory bowel disease3
Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy3
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service3
Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less3
Issue Information3
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes3
Trainee Oral Presentation Abstracts3
A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution2
2023 COSA ASM Exhibitor Listing2
Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer2
International speakers2
Encapsulated papillary carcinoma of the breast clinicopathological features and management: Could sentinel lymph node biopsy be exempted?2
Issue Information2
Sponsor Acknowledgements2
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?2
2
2
2023 ANZUP Annual Scientific Meeting, 9‐11 July 2023, Melbourne Convention Centre, Victoria, Australia2
Issue Information2
Less aggressive treatment for less aggressive disease? A retrospective single‐center study of pulmonary‐limited metastases associated with colorectal cancer2
Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis2
Impact of age on outcomes in young women with breast cancer2
Issue Information2
Issue Information2
Oral presentation abstracts2
Program in Detail2
Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study2
Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 20232
E74‐like factor 4 promotes the proliferation, invasion, and migration of colorectal cancer cells via long non‐coding RNA integrin subunit beta 8 antisense RNA 1‐mediated histone H3 lysine 27 trimethyl2
Participation in oral health screening among cancer survivors2
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study2
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non‐small cell lung cancer in locally advanced stage? Retrospective experience based on a sin2
Clinical application of preserving spontaneous breathing non‐intubation anesthesia in thoracoscopic surgery for lung cancer under ERAS concept2
Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India2
List of Poster Abstracts2
ANZUP Chair Welcome2
Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma2
Toxicity profile of patients treated with proton and carbon‐ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta‐analysis2
Issue Information2
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease2
PD‐L1 heterogeneity in patients with non–small cell lung cancer2
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy2
2
Telehealth adoption in cancer clinical trials: An Australian perspective2
Sponsor Acknowledgments2
Construction and validation of a novel tumor necrosis factor‐related apoptosis‐inducing ligand mutant MuR5S4‐TR2
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer2
A novel exosome‐related prognostic risk model for thyroid cancer2
2
International Speakers2
Organising Committee2
Poster Abstracts2
Awards and Scholarships2
2
2
2
Real‐world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective2
A feasibility study of modified docetaxel, cisplatin, and capecitabine for advanced gastric cancer followed by gastrectomy2
Clinical outcomes and prognostic factors of cone‐beam CT‐guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients2
2
Pneumocystis jirovecii Pneumonia in Cancer Patients, a Lethal Yet Fully Preventable Disease: Insights From a Tertiary Cancer Center in East India2
Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study2
Polysaccharide of Lactobacillus casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT21
Selective internal radiation therapy with yttrium‐90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma1
Population pharmacokinetics of doxorubicin: A systematic review1
Local ablative radiotherapy on oligo‐progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non–small cell lung cancer patients: A longer cohort1
Taxane‐induced neuropathy: How serious is this problem for patients with early breast cancer?1
Clinical and genetic characteristics of early‐stage multiple primary and independent primary lung adenocarcinoma patients1
Clinicopathological and treatment response characteristics of updated rhabdomyosarcoma histomolecular subtypes: An Asian population‐based study1
Highlighted Lectures and Awards 20211
Differences in lesion interpretation between radiologists in two countries: Lessons from a digital breast tomosynthesis training test set1
1
Arthralgia induced by endocrine therapy with or without cyclin‐dependent kinase 4/6 inhibitors in breast cancer: A systematic review and meta‐analysis1
Issue Information1
Pictorial essay on MRI local staging of rectal carcinoma: An easy approach1
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint Inhibitors1
ANZUP Fellowships and Awards1
Evaluating the Effect of Oral Famotidine in Preventing Hypersensitivity Reactions in Individuals Receiving Platinum‐Based Agents or Taxanes1
Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene‐addicted metastatic non‐small cell lung cancer (NSCLC) following combination chemotherapy‐immuno1
National Presenters and Chairs1
Active screening for lung cancer increases smoking abstinence in Australia1
Organising Committee1
Gail model and fifth edition of ultrasound BI‐RADS help predict axillary lymph node metastasis in breast cancer—A multicenter prospective study1
Reliability and validity of the Cancer Health Literacy Test – Chinese versions: CHLT‐30‐Chinese and CHLT‐6‐Chinese1
Modified response evaluation criteria in solid tumors: A better response evaluation criteria for patients with non‐squamous non‐small cell lung cancer after bevacizumab treatment1
National Speakers1
Exosome miR‐3184‐5p inhibits gastric cancer growth by targeting XBP1 to regulate the AKT, STAT3, and IRE1 signalling pathways1
Sponsor Acknowledgements1
Completion Rate of Paper‐Based and Electronic Patient Reported Outcome Measures in a Multidisciplinary Cancer Survivorship Clinical Setting1
Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries1
Real‐World Experience Using Brigimadlin (MDM2 Inhibitor) in an Australian Sarcoma Specialist Center Compared to Pivotal Clinical Trial Results1
Influencing factors of meaning in life in patients with advanced lung cancer undergoing radiochemotherapy: A cross‐sectional survey1
Comparison between flattening filter‐free (FFF) and flattened photon beam VMAT plans for the whole brain radiotherapy (WBRT) with hippocampus sparing1
Current landscape of cancer survivorship research in Australia1
Berberine and Lung Cancer: From Pure Form to Its Nanoformulations1
Glucose to lymphocyte ratio predicts prognoses in patients with colorectal cancer1
Program in Detail1
Sponsor acknowledgments1
Prevalence of highly actionable mutations among Indian patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis1
Issue Information1
Correlation of 18‐fluorodeoxyglucose uptake values on PET–CT scan with histological prognostic markers in breast cancer1
Issue Information1
International Speakers1
1
8th International Conference on Biomedical Engineering and Pharmaceutical Sciences (ICBEPS2023)1
The pathophysiology and current treatments for the subcutaneous panniculitis‐like T cell lymphoma: An updated review1
Trainee Oral Presentation Abstracts1
Program in Detail1
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series1
Clinical significance and prognostic value of circulating B10 cells in colorectal cancer1
Issue Information1
1
Convenor welcome1
Performance status as prognostic factor in phase III trials of first‐line chemotherapy of unresectable or metastatic pancreatic cancer: A trial‐level meta‐analysis1
Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis1
Issue Information1
Multi‐omic analysis of dysregulated pathways in triple negative breast cancer1
Poster Listing1
External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program1
Combinatorial approach of immuno‐proton therapy in cancer: Rationale and potential impact1
Convenors’ Welcome1
Issue Information1
Clinical outcomes of image‐guided percutaneous drainage of pericardial effusion in cancer patients: A single‐center retrospective analysis1
A message from HCRA Directors and the Symposium Scientific Committee1
Welcome from the Sydney Cancer Conference 2021 Chairs1
Rates of adherence to cancer treatment guidelines in Australia and the factors associated with adherence: A systematic review1
Consumers’ experiences, preferences, and perceptions of effectiveness in using telehealth for cancer care in Australia1
ANZUP MDT Masterclass Convenor Welcome1
Post‐prostatectomy Magnetic Resonance‐guided Radiotherapy on a 1.5 Tesla Magnetic Resonance Integrated Linear Accelerator: Feasibility, Toxicity, and Preliminary Clinical Outcomes1
Dynamic changes in systemic immune‐inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemot1
Annual Scientific Meeting Program1
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective1
A national survey of oncology physiotherapy services for cancer survivors in Australia1
Evaluation of molecular methods for plasma detection of EGFR mutations in non‐small cell lung cancer1
Real‐world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed‐dose combination to prevent chemotherapy‐induced nausea and vomiting among Malaysian patients receiving mo1
Management Experience of T1 Glottic Cancer Treated by CO2 Laser Surgery: A Cohort of 173 Patients1
Issue Information1
Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR‐30a‐5p/FOXD11
2022 COSA ASM Exhibitor Profiles1
Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses1
0.081516981124878